Conformational photoswitching of a synthetic peptide.

Foldamer database paper published. We have recently published a research paper on FoldamerDB, our database of peptidic foldamers. Foldamers are chemical oligomers that mimic the structural behavior of natural peptides, and proteins by folding into well-defined 3D conformation in solution. FoldamerDB is the first public database of peptidic foldamers, created with the aim to gather and provide.

Sophistication of foldamer form and function in vitro. in targeting transmembrane helices, continue to extend the goals and potential of foldamer research. Foldamers take shape. Natural biopolymers fold with fidelity, can exist as oligomers or discrete complexes, and possess kinetic and thermodynamic signatures that distinguish them from non-biological polymers and smaller molecules.

Research Themes in the Clayden Group Following the recent award of an ERC Advanced Grant to Jonathan Clayden we will shortly be advertising a number of Postdoctoral research fellowships. If you would like to receive information when these positions become open for application, please email a cv and covering letter.

New paper in Nature Chemistry accepted. Check it out: HERE. A breakthrough in the design of synthetic sugar receptors. Research results reported by these groups on synthesizing a foldamer able to selectively encapsulate fructose have indeed just been published today. This result is the first of its kind!

Welcome to the home page of the Biological Soft Matter Platform. Recent news. Foldamer database paper published. We have recently published a research paper on FoldamerDB, our database of peptidic foldamers. Foldamers are chemical oligomers that mimic the structural behavior of natural peptides, and proteins by folding into well-defined 3D conformation in solution. FoldamerDB is the first.

Biomaterials is the flagship title in Elsevier's biomaterials science portfolio; it sits alongside Materials Today Bio, Materials Science and Engineering C: Materials for Biological Applications and Biomaterials and Biosystems. As part of the broader Materials Today family, Biomaterials offers authors rigorous peer review, rapid decisions, and.

ChemComm ( Chemical Communications) is the Royal Society of Chemistry’s most cited journal, and has a long history of publishing exciting new findings of exceptional significance, across the breadth of chemistry. With its Communication format, we recognise the importance of rapid disclosure of your work, and we are proud that our times to.

In the Suga lab, our aim is to utilize organic chemistry techniques in combination with biology to tackle yet unresolved questions. In our inclusive research, we procure scientific knowledge leading to new concepts and develop novel technologies with broad applicability, which can extend to drug discovery.

The authors use the Seebach paper for making -peptides and then use their own research method in order to develop the peptide into a foldamer. “Well-defined secondary structures: Information-storing molecular duplexes and helical foldamers based on unnatural peptide backbones”.

LMU chemist Professor Ivan Huc, who heads a research group devoted to the study of Biomimetic Supramolecular Chemistry, has designed and synthesized a molecular structure which features a helical binding pocket that is made-to-measure for the recognition and capture of xylobiose, a member of the disaccharide class of carbohydrates to which sugar (sucrose) also belongs.

The focus of a growing number of research groups including our own is to achieve structures whose properties may lead to multitudes of applications both in and out of the biological realm. The development of most of the unnatural assembling and folding structures has been inspired by peptide and protein structures. For example, the pioneering.

Home Medical Research Research throws new light on the protection of cells against HIV infection. Research throws new light on the protection of cells against HIV infection. 20. Here is some news for people who wish to hear more about HIV infection. Apparently researchers have designed synthetic protein-like mimics with the help of human immunodeficiency virus (HIV) and molecular engineering.